These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8895162)

  • 1. Nerve growth factor circulating levels are increased in Kawasaki disease: correlation with disease activity and reduced angiotensin converting enzyme levels.
    Falcini F; Cerinic MM; Ermini M; Generini S; Lombardi A; Pignone A; Leoncini G; Tirassa P; Aloe L
    J Rheumatol; 1996 Oct; 23(10):1798-802. PubMed ID: 8895162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin converting enzyme: an in vivo and in vitro marker of endothelial injury.
    Matucci-Cerinic M; Jaffa A; Kahaleh B
    J Lab Clin Med; 1992 Sep; 120(3):428-33. PubMed ID: 1325530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of serum soluble interleukin-2R, interleukin-6 and C-reactive protein in the early diagnosis of Kawasaki disease].
    Peng Q; Wu Q; Chen CH; Hong H; Zhang LY
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):208-10. PubMed ID: 16787593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Decreased circulating endothelial progenitor cell function: relationship with serum concentrations of high-sensitivity C-reactive protein in children with Kawasaki disease].
    Xu MG; Men LN; Wang HX; Zu Y; Zhao CY; Zhao X; Cai HB; Meng XC; Wang T
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Jul; 12(7):513-7. PubMed ID: 20637144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoprotegerin serum levels in Kawasaki disease: an additional potential marker in predicting children with coronary artery involvement.
    Simonini G; Masi L; Giani T; Piscitelli E; Cimaz R; Vierucci S; Brandi ML; Falcini F
    J Rheumatol; 2005 Nov; 32(11):2233-8. PubMed ID: 16265708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum level of angiotensin-converting enzyme in sarcoidosis. Attempted correlation with the clinical activity of the disease (author's transl)].
    Larzul JJ; Le Treut A; Couliou H; Beaumont D; Delaval P; Sapene M; de Labarthe B
    Nouv Presse Med; 1981 Feb; 10(9):675-8. PubMed ID: 6259614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
    Tse SM; Silverman ED; McCrindle BW; Yeung RS
    J Pediatr; 2002 Apr; 140(4):450-5. PubMed ID: 12006960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating adiponectin levels in Kawasaki disease.
    Takeshita S; Takabayashi H; Yoshida N
    Acta Paediatr; 2006 Oct; 95(10):1312-4. PubMed ID: 16982510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A polymorphism in plasma platelet-activating factor acetylhydrolase is involved in resistance to immunoglobulin treatment in Kawasaki disease.
    Minami T; Suzuki H; Takeuchi T; Uemura S; Sugatani J; Yoshikawa N
    J Pediatr; 2005 Jul; 147(1):78-83. PubMed ID: 16027700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of angiotensin-converting enzyme inhibitor on matrix metalloproteinase-9 activity in patients with Kawasaki disease.
    Inoue N; Takai S; Jin D; Okumura K; Okamura N; Kajiura M; Yoshikawa S; Kawamura N; Tamai H; Miyazaki M
    Clin Chim Acta; 2010 Feb; 411(3-4):267-9. PubMed ID: 19945447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are Angiotensin Converting Enzyme and von Willebrand factor circulating levels useful surrogate parameters to monitor disease activity in Kawasaki disease?
    Falcini F; Generini S; Pignone A; Leoncini G; Cimaz R; Partsch G; Matucci-Cerinic M
    Endothelium; 1999; 6(3):209-15. PubMed ID: 10365772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical features of recurrent Kawasaki disease in 20 children].
    Zou LX; Gong FQ
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Oct; 10(5):617-9. PubMed ID: 18947484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Circulating interleukin-4 levels in acute phase Kawasaki disease].
    Hirao J; Hibi S; Andoh T; Ichimura T
    Arerugi; 1996 Oct; 45(10):1137-9. PubMed ID: 8958662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute Kawasaki disease is associated with reverse regulation of soluble receptor for advance glycation end products and its proinflammatory ligand S100A12.
    Wittkowski H; Hirono K; Ichida F; Vogl T; Ye F; Yanlin X; Saito K; Uese K; Miyawaki T; Viemann D; Roth J; Foell D
    Arthritis Rheum; 2007 Dec; 56(12):4174-81. PubMed ID: 18050248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated circulating tumor necrosis factor-alpha in patients with Kawasaki disease.
    Maury CP; Salo E; Pelkonen P
    J Lab Clin Med; 1989 May; 113(5):651-4. PubMed ID: 2715685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose intravenous immunoglobulin downregulates the activated levels of inflammatory indices except erythrocyte sedimentation rate in acute stage of Kawasaki Disease.
    Lee KY; Lee HS; Hong JH; Han JW; Lee JS; Whang KT
    J Trop Pediatr; 2005 Apr; 51(2):98-101. PubMed ID: 15677370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of myeloid-related protein-8 and -14 in patients with acute Kawasaki disease.
    Hirono K; Foell D; Xing Y; Miyagawa-Tomita S; Ye F; Ahlmann M; Vogl T; Futatani T; Rui C; Yu X; Watanabe K; Wanatabe S; Tsubata S; Uese K; Hashimoto I; Ichida F; Nakazawa M; Roth J; Miyawaki T
    J Am Coll Cardiol; 2006 Sep; 48(6):1257-64. PubMed ID: 16979015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephromegaly in children with Kawasaki disease: new supporting evidence for diagnosis and its possible mechanism.
    Huang HP; Lai YC; Tsai IJ; Chen SY; Cheng CH; Tsau YK
    Pediatr Res; 2008 Feb; 63(2):207-10. PubMed ID: 18091351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hair loss as a sign of Kawasaki disease.
    Nabavizadeh SH; Safari M; Amin R
    Iran J Allergy Asthma Immunol; 2006 Dec; 5(4):199-200. PubMed ID: 17237574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased serum levels of macrophage migration inhibitory factor in patients with Kawasaki disease.
    Lee TJ; Chun JK; Yeon SI; Shin JS; Kim DS
    Scand J Rheumatol; 2007; 36(3):222-5. PubMed ID: 17657678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.